Picture ConsulTech GmbH Forschungszulage 650x80px
Document › Details

Onxeo S.A.. (9/29/16). "Press Release: Onxeo Launches Capital Increase [THIS PRESS RELEASE IS NOT FOR DISTRIBUTION IN THE UNITED STATES, CANADA, JAPAN, OR AUSTRALIA]". Paris & Copenhagen.

Region Region EUR(WEST)+AM(NORTH)
Organisations Organisation Onxeo S.A. (Euronext Paris, Nasdaq Copenhagen: ONXEO)
  Group Onxeo (Group)
  Organisation 2 Oddo & Cie.
  Group Oddo (Group)
Products Product Livatag®
  Product 2 AsiDNA™ (Onxeo / DNA Therapeutics)
Index term Index term Onxeo–SEVERAL: investment, 201609 capital increase €12.5m with 5.4m new ordinary shares at €2.3/share to US + European institutional investors
Persons Person Gréciet, Judith (BioAlliance Pharma 201306 CEO + France Biotech 201508 Board Member)
  Person 2 Fellmann, Nicolas (Onxeo 201606 CFO)

Record changed: 2016-10-03


Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

More documents for Onxeo (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture Kentro Design Corporate and Web Design Berlin 650x65px

» top